Copanlisib (BAY 80-6946) is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. By inhibiting the PI3K signaling pathway, Copanlisib may impede tumor cell growth and survival in certain tumor populations. Dysregulated PI3K signaling, often linked to tumorigenesis, may also contribute to tumor resistance to various antineoplastic agents.
Molecular Weight:
480.52
Purity:
99.88%
CAS Number:
[1032568-63-0]
Formula:
C23H28N8O4
Target:
PI3K|||Apoptosis
T6322
* VAT and and shipping costs not included. Errors and price changes excepted